Art

J-GLOBAL ID：202002277162997567   Reference number：20A0226309

A 3-Year Overall Survival Update From a Phase 2 Study of Chemoselection With DCF and Subsequent Conversion Surgery for Locally Advanced Unresectable Esophageal Cancer

局所進行切除不能食道癌に対するDCFおよびその後の転換手術による化学選択の第2相試験からの3年間の全生存率更新【JST・京大機械翻訳】

Author (20)： Yokota Tomoya (Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan) ,  Kato Ken (Gastrointestinal Oncology Division, National Cancer Center Hospital, Tokyo, Japan) ,  Hamamoto Yasuo (Division of Gastroenterology and Hepatology, Keio University School of Medicine, Tokyo, Japan) ,  Tsubosa Yasuhiro (Division of Esophageal Surgery, Shizuoka Cancer Center, Shizuoka, Japan) ,  Ogawa Hirofumi (Division of Radiation Oncology, Shizuoka Cancer Center, Shizuoka, Japan) ,  Ito Yoshinori (Department of Radiation Oncology, National Cancer Center Hospital, Tokyo, Japan) ,  Hara Hiroki (Department of Gastroenterology, Saitama Cancer Center, Saitama, Japan) ,  Ura Takashi (Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan) ,  Kojima Takashi (Department of Gastroenterology, National Cancer Center Hospital East, Chiba, Japan) ,  Chin Keisho (Department of Gastroenterology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan) ,  Hironaka Shuichi (Clinical Trial Promotion Department, Chiba Cancer Center, Chiba, Japan) ,  Kii Takayuki (Cancer Chemotherapy Center, Osaka Medical College Hospital, Osaka, Japan) ,  Kojima Yasushi (Department of Gastroenterology, National Center for Global Health and Medicine, Tokyo, Japan) ,  Akutsu Yasunori (Department of Frontier Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan) ,  Matsushita Hisayuki (Department of Surgery, Tochigi Cancer Center, Tochigi, Japan) ,  Kawakami Kentaro (Department of Medical Oncology, Tochigi Cancer Center, Tochigi, Japan) ,  Mori Keita (Clinical Trial Coordination Office, Shizuoka Cancer Center, Shizuoka, Japan) ,  Makiuchi Takashi (Clinical Data Management, Clinical Research Data Center, National Cancer Center Hospital, Tokyo, Japan) ,  Nagumo Rie (Clinical Data Management, Clinical Research Data Center, National Cancer Center Hospital, Tokyo, Japan) ,  Kitagawa Yuko (Department of Surgery, Keio University School of Medicine, Tokyo, Japan)
Material： Annals of Surgical Oncology
Volume： 27  Issue： 2  Page： 460-467  Publication year： 2020 
JST Material Number： W1826A  ISSN： 1068-9265  Document type： Article
Article type： 原著論文  Country of issue： Germany, Federal Republic of (DEU)  Language： ENGLISH (EN)

Abstract/Point： A multicenter phase 2 trial an...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A0226309&from=J-GLOBAL&jstjournalNo=W1826A") }}

Thesaurus term： characterization ,  *phase 2 study ,  confidence interval ,  drug therapy ,  *esophageal tumor ,  Distant metastases ,  primary site ,  Concurrent chemoradiotherapy ,  platinum complex ,  antitumor drug ,  ammine complex ,  chloro complex
Semi thesaurus term： cisplatin ,  局所進行食道癌 ,  長期観察 ,  R0切除 ,  *切除不能 ,  *全生存率 ,  *切除不能食道がん , 【Automatic Indexing@JST】

JST classification (4)： Chemistry,biochemistry and pathology of tumors(=neoplasms)  (GE02030N) ,  Gene expression  (EC02040Q) ,  Tumors(=neoplasms)of digestive system  (GH04000D) ,  Surgical treatment for tumors  (GE03033T)

Terms in the title (8)： 切除不能食道癌 ,  DCF ,  転換 ,  手術 ,  化学 ,  第2相試験 ,  全生存率 ,  更新